Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 121Neoplasm Metastasis 12Prostate Cancer Metastatic 4Oligometastatic Prostate Cancer 3Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 3Metastatic Hormone-sensitive Prostate Cancer 3Adenocarcinoma 3Radiation Injuries 2Prostatic Diseases 2Prostate CA 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Neoplasms 2Metastatic Castration-resistant Prostate Cancer 2Urologic Diseases 1Urogenital Neoplasms 1Triple Negative Breast Neoplasms 1Stage IV Prostate Adenocarcinoma AJCC v7 1Stage I Prostate Adenocarcinoma 1Salivary Gland Neoplasms 1Recurrence 1Prostatic Neoplasms, Castration-Resistant 1Prostate Adenocarcinoma 1PSA Level Greater Than 0.03 1Oligorecurrent and Oligoprogressive Prostate Cancer Patients 1Non-metastatic, Hormone naïve Prostate Cancer 1Neoplasm Recurrence, Local 1Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) 1Metastatic Hormone-Sensitive Prostate Cance 1Metastatic Hormone Sensitive Prostate Cancer 1Metastatic Castration-sensitive Prostate Cancer 1

Interventions

Androgen Antagonists 2fasudil 1Surgical Procedures, Operative 1Radiosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Prostate CA × Androgen Antagonists × Clear all
NCT06861192 2025-11-18

Clinical Study of Fasudil Hydrochloride and PD1 Inhibitor Combined With Androgen Deprivation in Neoadjuvant Therapy of Prostate Cancer

Zhongda Hospital

Phase 2/3 Recruiting
83 enrolled
Genitourinary

Prostate CA

NCT06834321 2025-09-08

Clinical Study on Neoadjuvant Therapy of Homoharringtonine Combined With Androgen Deprivation for Prostate Cancer

Zhongda Hospital

Phase 2 Recruiting
96 enrolled
Genitourinary

Prostate CA

Data powered by HemOnc (CC BY 4.0) Colophon âš¡